# Supplementary protection certificate for medicinal products. Recast

European Parliament procedure 2023/0130(COD) (COD - Ordinary legislative procedure (ex-codecision procedure), 9th term, committee JURI). Stage: Awaiting Council's 1st reading position. 108 committee amendments tabled by 3 Members between 2023-11-14 and 2023-11-14.

## What the amendments focus on

This dossier is a recast of the rules on supplementary protection certificates for medicinal products. The amendments address protection conditions tied to a basic patent, avoiding overprotection through one certificate per product, the maximum duration of protection and paediatric extension, a centralised application examined under an Office with national examiners, fees, third-party observations, Boards of Appeal, generics and biosimilars, and disclosure of public financial support for research.

## Most active Members on this file

| Member | Country | Group | Amendments | Markdown |
|---|---|---|---|---|
| Daniel BUDA | Romania | PPE | 102 | https://amendeu.com/md/meps/125012.md |
| Javier ZARZALEJOS | Spain | PPE | 76 | https://amendeu.com/md/meps/197606.md |
| Marie TOUSSAINT | France | Verts/ALE | 38 | https://amendeu.com/md/meps/97236.md |

## Official source documents

- PE756.105: https://www.europarl.europa.eu/doceo/document/JURI-AM-756105_EN.pdf

Full amendment texts, votes and exports: https://amendeu.com/dossiers/2023-0130-COD · machine-readable: https://amendeu.com/data/dossiers/2023-0130-COD.json

---

Source: AmendEU (amendeu.com), built from Parltrack (ODbL), European Parliament Open Data ((c) European Union) and official Parliament documents. Aggregates CC BY 4.0.
Data refreshed: 2026-07-27. Human-readable version: https://amendeu.com/dossiers/2023-0130-COD
When citing, attribute to "AmendEU (amendeu.com)".